Acyanotic Heart Disease refers to a group of congenital heart defects that do not cause a significant decrease in oxygen levels in the blood. These conditions often involve structural abnormalities in the heart, such as ventricular septal defects or atrial septal defects, which allow blood to flow abnormally but still maintain adequate oxygenation. Patients may experience symptoms like fatigue or difficulty breathing, but they typically do not exhibit a bluish tint to the skin, known as cyanosis. Treatment for Acyanotic Heart Disease may include medication, monitoring, or surgical intervention, depending on the severity of the defect. Early diagnosis and management are crucial to prevent complications and improve quality of life. Regular follow-ups with a cardiologist are essential for ongoing care and assessment of heart function.